metastatic disease
Showing 1 - 25 of >10,000
Prediction of True Oligo-metastatic Disease.
Recruiting
- Oligometastatic Disease
- Genetic and immunologic assessments
-
Naples, ItalyAlessandro Ottaiano
Apr 7, 2023
MiRNA in Detecting Active Germ Cell Tumors in Early Suspected
Recruiting
- Malignant Testicular Germ Cell Tumor
- Non-Interventional Study
-
Los Angeles, California
- +1 more
Sep 28, 2023
Luminal Metastatic breAst caNcer in Real-life Clinical pracTice
Completed
- HR+/HER2- Breast Cancer
- +2 more
-
Moscow, Russian FederationRussian Society of Clinical Oncology
Mar 29, 2023
Metastatic Cancer Trial in La Jolla (CBI, CBI plus SBRT)
Active, not recruiting
- Metastatic Cancer
- CBI
- CBI plus SBRT
-
La Jolla, CaliforniaUCSD Moores Cancer Center
May 16, 2022
Advanced Cholangiocarcinoma, Advanced Hepatocellular Carcinoma, Advanced Malignant Solid Tumor Trial in Los Angeles (Biospecimen
Recruiting
- Advanced Cholangiocarcinoma
- +6 more
- Biospecimen Collection
- +3 more
-
Los Angeles, California
- +1 more
Mar 31, 2023
Metastatic Breast Cancer, Breast Cancer Stage IV Trial in São Paulo
Recruiting
- Metastatic Breast Cancer
- Breast Cancer Stage IV
-
São Paulo, SP, BrazilHcor
Sep 26, 2022
Oligometastatic Hormone Sensitive Prostate Cancer Trial in Florence (SBRT on all sites of metastatic disease+Apalutamide)
Not yet recruiting
- Oligometastatic Hormone Sensitive Prostate Cancer
- SBRT on all sites of metastatic disease+Apalutamide
-
Florence, ItalyAOU Careggi Radiation Oncology Unit
Jan 29, 2023
Breast Cancer Trial in Sydney ([68Ga]GA-NeoB)
Recruiting
- Breast Cancer
-
Sydney, New South Wales, AustraliaSt Vincent's Hospital
May 22, 2023
Metastatic Cancer Trial in London (Stereotactic ablative radiotherapy - Level 1, Stereotactic ablative radiotherapy - Level 2,
Recruiting
- Metastatic Cancer
- Stereotactic ablative radiotherapy - Level 1
- +4 more
-
London, Ontario, CanadaLondon Health Sciences Centre - London Regional Cancer Program
Apr 4, 2022
Oligometastasis, Metastatic Cancer Trial in Cary, Durham, Raleigh
Recruiting
- Oligometastasis
- Metastatic Cancer
-
Cary, North Carolina
- +4 more
Apr 21, 2022
Colorectal Carcinoma, Liver Metastases Trial in Copenhagen (MWA, SBRT)
Recruiting
- Colorectal Carcinoma
- Liver Metastases
- MWA
- SBRT
-
Copenhagen, DenmarkRighospitalet
Jan 21, 2022
Malignant Tumor of Prostate Trial in Cleveland ([F-18] NaF PET/CT, [F-18] fluciclovine PET/CT)
Withdrawn
- Malignant Neoplasm of Prostate
- [F-18] NaF PET/CT
- [F-18] fluciclovine PET/CT
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center, Case Comprehensiv
Mar 21, 2022
Pancreatic Cancer, Advanced Cancer, Metastatic Cancer Trial in Beijing (Later-line therapy)
Recruiting
- Pancreatic Cancer
- +2 more
- Later-line therapy
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Apr 10, 2023
Culture of Circulating Tumor Cells Isolated From Cancer
Completed
- Circulating Tumor Cells
- Blood draw
-
Chapel Hill, North CarolinaUniversity of North Carolina at Chapel Hill, Department of Radia
Dec 21, 2021
Colorectal Cancer Metastatic Disease in Middle-Norway
Active, not recruiting
- Neoplasms, Colorectal
- Neoplasm Metastasis
- cancer treatment and follow-up according to current regional and national guidelines
-
Kristiansund, Norway
- +6 more
Feb 10, 2022
Metastatic Pancreatic Cancer Trial in Rotterdam (MesoPher, Mitazalimab)
Recruiting
- Metastatic Pancreatic Cancer
- MesoPher
- Mitazalimab
-
Rotterdam, Zuid-Holland, NetherlandsErasmus MC
Dec 6, 2022
Thyroid Cancer Trial in Medellin (Traditional neck dissection approach, Anterior neck dissection approach)
Recruiting
- Thyroid Cancer
- Traditional neck dissection approach
- Anterior neck dissection approach
-
Medellin, Antioquia, ColombiaHospital Alma Mater de Antioquia
Nov 20, 2023
Breast Cancer Trial in New York (Multicomponent Adherence Intervention)
Recruiting
- Breast Cancer
- Multicomponent Adherence Intervention
-
New York, New YorkColumbia University Medical Center
Nov 6, 2023
Adenocarcinoma, Stomach Tumor, Gastroesophageal-junction Cancer Trial in Shanghai (radiation, biological, drug, procedure)
Recruiting
- Adenocarcinoma
- +8 more
- Radiotherapy targeted to the primary lesion
- +7 more
-
Shanghai, ChinaFudan University Shanghai Cancer Center
Nov 7, 2023
DESTINY Breast Respond HER2-low Europe
Not yet recruiting
- Unresectable Breast Cancer
- +2 more
- Trastuzumab deruxtecan
- (no location specified)
Jul 6, 2023
Unresectable Metastatic Colorectal Cancer Trial (ABBV-400, Bevacizumab, Folinic Acid)
Not yet recruiting
- Unresectable Metastatic Colorectal Cancer
- ABBV-400
- +4 more
- (no location specified)
Oct 25, 2023
Metastatic Cancer, Solid Tumor Cancer, Lymphoproliferative Disorders Trial in Boulder (Written Exposure Therapy)
Recruiting
- Metastatic Cancer
- +5 more
- Written Exposure Therapy
-
Boulder, ColoradoUniversity of Colorado Boulder
Sep 13, 2023
Metastatic Castration-resistant Prostate Cancer, Prostate Cancer Metastatic, Castrate Resistant Prostate Cancer Trial in
Not yet recruiting
- Metastatic Castration-resistant Prostate Cancer
- +2 more
- 177Lu HTK03170
- 68Ga-HTK03149
-
Vancouver, British Columbia, CanadaBC Cancer
Nov 28, 2022
Metastatic Colorectal Cancer Trial (Anti-PD-1 Monoclonal Antibody + Capecitabine)
Not yet recruiting
- Metastatic Colorectal Cancer
- Tislelizumab + Capecitabine
- Best supportive care
- (no location specified)
Sep 22, 2022
Leptomeningeal Disease Trial in Germany (Nivolumab [Opdivo])
Recruiting
- Leptomeningeal Disease
- Nivolumab [Opdivo]
-
Freiburg, Germany
- +6 more
Nov 2, 2022